Predictive Submits Emergency Use Authorization Application for Treatment of Acute Respiratory Distress Syndrome Secondary to COVID -19 with Umbilical Cord Mesenchymal Stem Cells
13 avr. 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, April 13, 2020 (GLOBE NEWSWIRE) -- Predictive Biotech, a wholly owned subsidiary of Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), announced that on...
Predictive Technology Group Announces Initial Order of One Million Units of the Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test from Distribution Partner, Wellgistics, LLC.
08 avr. 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), today shared...
Predictive Technology Group Announces Distribution Agreement with Wellgistics, LLC for Its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point-of-Care
03 avr. 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, April 03, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in the development of genetic and molecular diagnostics and...
Predictive Technology Group and Manufacturing Partners Provide Updates of Its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care
30 mars 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, March 30, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in the development of genetic and molecular diagnostics and...
Predictive Technology Group Announces Launch of Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care
25 mars 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in the development of genetic and molecular diagnostics and...
Predictive Technology Group Addresses Use of Mesenchymal Stem Cells in Treatment of Secondary Issues Related to Coronavirus
17 mars 2020 11h45 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, March 17, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), today announced that last week it began communication with domestic...
Atrin Pharmaceuticals Adds Critical Genomics Capabilities in Advance of Initiating First Clinical Trial Through Ongoing Collaboration with Predictive Technology Group
25 févr. 2020 08h00 HE
|
Predictive Technology Group Inc
DOYLESTOWN, Pa., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Atrin Pharmaceuticals, a private biopharmaceutical company pioneering the discovery and development of proprietary molecules targeting DNA Damage...
Predictive Technology Group Reports Second Quarter Fiscal 2020 Financial Results and Provides Corporate Update
14 févr. 2020 16h26 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in helping identify barriers that impact women’s health and...
Predictive Technology Group Announces Beta Test Results for its ARTguide™ Test
11 févr. 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in helping identify barriers that impact women’s health and...
Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration
28 janv. 2020 08h00 HE
|
Predictive Technology Group Inc
SALT LAKE CITY, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) and Atrin Pharmaceuticals LLC are entering into a collaboration agreement to develop molecular...